HOME >> BIOLOGY >> NEWS
DNA transcription is tuned to specific cells

September 14, 2001 -- Researchers have found a new example of how the machinery that controls the transcription of DNA to messenger RNA (mRNA) is tailored to specific cells or genes.

In studies in mice, the researchers discovered that TAFII105, a key component of the transcription machinery, is specific to egg-forming cells in ovaries. The finding emphasizes a newly emerging theme in molecular biology -- that DNA transcription is not standardized throughout cells but is instead adapted to control cell-specific gene expression. The scientists believe that future research is likely to reveal other cell-specific transcription components that ensure that genes are expressed in a customized way according to the needs of each cell.

The finding that TAFII105 is specifically involved in controlling genes for egg formation also hints that some inherited forms of sterility in women may be due to mutations in the TAFII105 gene, said the scientists.

In an article published in the September 14, 2001, issue of the journal Science, Howard Hughes Medical Institute investigator Robert Tjian and colleagues Richard N. Freiman, Shane R. Albright, Shuang Zheng, William C. Sha and Robert E. Hammer detailed how they traced the transcriptional role of TAFII105 to granulosa cells in the ovaries of mice. Granulosa cells surround the developing egg, called the oocyte, and foster its development.

The scientists also used DNA microarrays to explore which genes were switched off in knockout mice that lacked a functional copy of the TAFII105 gene. The TAFII105 protein is one of a family of TAF proteins that are subunits of a large complex called the transcription factor TFIID.

"When TFIID and all its associated factors were discovered ten years ago, we found it in every cell we looked at," said Tjian, who is at the University of California at Berkeley. "We thought it would be invariant from cell to cell, since it was so fundamental to the cells in transcri
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
13-Sep-2001


Page: 1 2 3

Related biology news :

1. Targeting transcription: New insights into turning genes on
2. UT Southwestern scientists prove certain proteins play unexpected roles in genetic transcription
3. Tidying up transcription factors
4. Post-transcriptional regulation of COX2 in tumor cells
5. Novel means for stopping transcription found, Hopkins scientists report
6. Discovery will change the way researchers look at DNA transcription, scientists say
7. Welch honors Kornberg for insights into DNA transcription
8. Different levels of transcription factor coax immune cell progenitors down different developmental pathways
9. 3-D structure of human transcription factor proteins revealed
10. Sequence of human chromosome 7 is fine-tuned and finished
11. Veterans with Gulf War syndrome have damage in specific, primitive portion of nervous system

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DNA transcription tuned specific cells

(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of ... report to their offering. One ... adoption of multimodal biometric systems. Multimodal biometric systems ... for verification and identification purposes. This helps to ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a ... $2.3 million in Series A1 funding led by UK-based ... also participated in the investment round. "We ... healthcare community adopts next-generation sequencing and seeks new approaches ... Reid Robison , MD MBA, and CEO of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: